Astellas snaps up cancer antibody specialists Agensys
Japanese drugmaker Astellas has agreed to acquire US biotech firm Agensys as part of its plan to ramp up antibody research, especially in the field of cancer.
Japanese drugmaker Astellas has agreed to acquire US biotech firm Agensys as part of its plan to ramp up antibody research, especially in the field of cancer.
GVK Bio has reinforced its claim to be India's top contract research organisation with a 100-crore ($25m) push from a private investment company. The funds will be used to expand its drug discovery services and push further into preclinical and...
Reports emerged in the German press yesterday claiming that AstraZeneca has found a buyer for its Plankstadt manufacturing facility.
Specialty pharmaceutical company Akorn has signed up with India-based Cipla in an exclusive manufacturing and supply agreement for an undisclosed inhaled drug.
Researchers have developed a nanoparticle signalling system that can be used as cellular 'nano-flares' that enable the visualisation and quantification of RNA in living cells.